Sign in
Taking people in United StatesNo phase

Testing an MBI for Smoking Cessation and Alcohol Use Among Cancer Survivors

Key facts

Who runs it
H. Lee Moffitt Cancer Center and Research Institute
Where
Tampa, United StatesSee the site
Trial code
Status
Recruiting
People taking part
600 people, planned
Started
15 May 2026
Expected to end
Dec 2029
Type of study
Interventional, 2 groups
Treatments tested
  • Mindfulness-Based Relapse Prevention for Smoking and Alcohol (MBRP-SA)
  • Quitline Support
Record updated
18 May 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • ≥18 years old
  • History of a cancer diagnosis at any point in lifetime
  • Smoked ≥1 cigarette/day in past month
  • At least one binge drinking episode in past month or exceeds weekly drinking limits
  • Motivated to quit smoking and modify alcohol use in next 30 days
  • Valid home address in Florida
  • English-speaking, reading, and writing ability

Who cannot take part

  • Current use of tobacco cessation medication or other treatments to quit smoking
  • Active psychotic disorder
  • History of severe alcohol withdrawal
  • Pregnancy or lactation
  • End-of-life or hospice care
  • Household member already enrolled

Where in United States

  • Moffitt Cancer CenterTampa, United StatesContact: Christine Vinci, PhD (principal investigator)Taking people

About the trial

What the trial wants to find out

This study will examine the efficacy of Mindfulness-Based Relapse Prevention for Smoking and Alcohol (MBRP-SA) compared to standard care among cancer survivors who smoke cigarettes and engage in at-risk alcohol use. Investigators will evaluate implementation outcomes through structured stakeholder interviews across medical centers, cancer-focused organizations, and community-based programs in Florida, and will conduct a cost-assessment and an incremental cost-effectiveness analysis of the two conditions.

The 2 groups in the trial

  • Mindfulness-Based Relapse Prevention for Smoking and Alcohol (MBRP-SA)Treatment being tested

    Participants randomized to this condition will receive a mindfulness-based intervention delivered in a group format via Zoom.

  • Quitline SupportTreatment being tested

    Participants randomized to this condition will be connected to the Florida Tobacco Quitline for smoking cessation services, as well as receive community referrals for alcohol use treatment.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Smoking Cessation and Alcohol Use Among Cancer Survivors: Investigating the Efficacy of a Mindfulness-Based Intervention
Record updated
18 May 2026